Her research focuses on the functional impact of Copy Number Variants (CNVs) in human pathologies. More precisely, she is developing bioinformatics tools in order to improve rare-disease diagnosis and patient stratification in a multi-site clinical setting. She uses machine learning and federated learning methods to implement a pathogenecity scoring of CNVs.
